As winter sets in, many people enjoy a hot mug of cocoa, snuggly sweaters, and outdoor activities such as walking through town to watch the lighting of the town tree or skiing with friends. There are ...
A high prevalence of cardiovascular risk factors, including arterial hypertension, was observed. Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia ...
Researchers observed an increase in both CXCR4 and CD5 levels as the cells progressed to later stages of the cell cycle, particularly in the S/G2/M phases. A critical subpopulation of chronic ...
There is a significant disparity between patient perception of treatment promptness in HAE and reality, with treatment delay during attacks linked to treatment-related anxiety. There is significant ...
Circulating levels of C1INH were significantly lower among carriers of rare and more harmful SERPING1 variants. A statistically significant elevated lifetime risk for venous thromboembolism (VTE) has ...
Improvements in signs and symptoms of psoriasis, as well as quality of life, were reported among Japanese individuals with generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP) in the ...
Dried blood spot screening is potentially a powerful tool for screening HAE in at-risk populations. An outreach program using dried blood spot (DBS) tests is a promising strategy to overcome family ...
AVO therapy offered sustained remission and undetectable MRD in patients with TP53 aberrations. “We previously reported early results of a phase II, investigator-initiated trial of AVO . . .
Patients underwent follow-up evaluations on days 4, 10, and 21 post-RS, followed by monthly assessments extending u to 6 months. It is well known that individuals with hemophilia are at an elevated ...
This case underscores the importance of individualized treatment plans and the need for meticulous perioperative care in patients with bleeding disorders. Among individuals with hemophilia, ...
There were no serious adverse events in children who underwent sessions of robot-assisted gait therapy with the device. ATLAS 2030, the medical lower-body exoskeleton for children is safe for patients ...